{"id":27122,"date":"2016-01-07T09:05:33","date_gmt":"2016-01-07T14:05:33","guid":{"rendered":"http:\/\/www.bumc.bu.edu\/busm\/?p=27122"},"modified":"2016-01-07T10:16:10","modified_gmt":"2016-01-07T15:16:10","slug":"wolozin-wins-alzheimers-disease-drug-discovery-award","status":"publish","type":"post","link":"https:\/\/www.bumc.bu.edu\/camed\/2016\/01\/07\/wolozin-wins-alzheimers-disease-drug-discovery-award\/","title":{"rendered":"Wolozin Wins Alzheimer\u2019s Disease Drug Discovery Award"},"content":{"rendered":"<p><strong><img loading=\"lazy\" src=\"\/camed\/files\/2013\/12\/wolozin-headshot-for-web.jpg\" alt=\"wolozin-headshot-for-web\" class=\"alignright size-full wp-image-7959\" height=\"273\" width=\"200\" \/><\/strong>Research that leads to improved therapies for Alzheimer\u2019s disease (AD) patients is one goal of\u00a0 Boston University School of Medicine professor of pharmacology and neurology Benjamin Wolozin, MD, PhD. He\u00a0 was one of six researchers awarded a two-year, $500,000 award in\u00a0 Alzheimer\u2019s<strong> <\/strong>Disease Drug Discovery Research by the Edward N. &amp; Della L. Thome Memorial Foundation.<\/p>\n<p>Wolozin has been studying the pathophysiology of AD, amyotrophic lateral sclerosis and Parkinson\u2019s disease (PD) for nearly 20 years and has made numerous contributions to the current field of understanding of neurodegenerative diseases. He has published more than 150 papers and book chapters on the topic in such high impact journals as <em>Science, Nature <\/em>and <em>PNAS<\/em>. He also holds four patents in the AD and PD fields and is the co-founder of the biotechnology company Aquinnah Pharmaceuticals, Inc.<em><span style=\"text-decoration: underline;\"> <\/span><\/em><\/p>\n<p>The Edward N. &amp; Della L. Thome Memorial Foundation was created in 2002 with the mission of advancing the health of older adults through support of direct service projects and medical research on disease and disorders affecting them. Each year they award $500,000 to a faculty member at a non-profit academic, medical, non-governmental or research institution in the United States with the purpose of furthering this objective.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>One of six researchers awarded a two-year, $500,000 award in Alzheimer\u2019s Disease Drug Discovery Research by the Edward N. &#038; Della L. Thome Memorial Foundation.<\/p>\n","protected":false},"author":903,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[91,143,90],"tags":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/posts\/27122"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/users\/903"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/comments?post=27122"}],"version-history":[{"count":1,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/posts\/27122\/revisions"}],"predecessor-version":[{"id":27123,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/posts\/27122\/revisions\/27123"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/media?parent=27122"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/categories?post=27122"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/tags?post=27122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}